Cargando…

Exploring Essential Issues for Improving Therapeutic Cancer Vaccine Trial Design

SIMPLE SUMMARY: Therapeutic cancer vaccines have failed to demonstrate clinical improvements in phase III clinical trials over the past two decades. This has led to a rather discouraging view regarding their role in the field of cancer immunotherapy. Herein, we critically examine important issues fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baxevanis, Constantin N., Fortis, Sotirios P., Ardavanis, Alexandros, Perez, Sonia A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600460/ https://www.ncbi.nlm.nih.gov/pubmed/33050520 http://dx.doi.org/10.3390/cancers12102908

Ejemplares similares

Association between Intratumoral CD8+ T Cells with FoxP3+ and CD163+ Cells: A Potential Immune Intrinsic Negative Feedback Mechanism for Acquired Immune Resistance
por: Fortis, Sotirios P., et al.
Publicado: (2022)

DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine
por: Anastasopoulou, Eleftheria A, et al.
Publicado: (2015)

Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
por: Fortis, Sotirios P., et al.
Publicado: (2017)

Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
por: Fortis, Sotirios P., et al.
Publicado: (2017)

The Prognostic Significance of Selected HLA Alleles on Prostate Cancer Outcome
por: Stokidis, Savvas, et al.
Publicado: (2023)

HLA Class I Allele Expression and Clinical Outcome in De Novo Metastatic Prostate Cancer
por: Stokidis, Savvas, et al.
Publicado: (2020)

The thin red line between the immune system and cancer evolution
por: Baxevanis, Constantin N., et al.
Publicado: (2022)

Combination Immunotherapy in Prostate Cancer
por: Baxevanis, Constantin N., et al.
Publicado: (2022)

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence
por: Mittendorf, Elizabeth A., et al.
Publicado: (2016)

Immune profiling of breast cancer patients: relationship between tumour antigen T cell responses with suppressor and effector leukocyte populations
por: Janssen, Nicole, et al.
Publicado: (2015)

Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs
por: Thomaidou, Arsinoe C., et al.
Publicado: (2022)

Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer
por: Goulielmaki, Maria, et al.
Publicado: (2023)

A Blood-Based Immune Gene Signature with Prognostic Significance in Localized Prostate Cancer
por: Fortis, Sotirios P., et al.
Publicado: (2023)

Radiotherapy-Related Gene Signature in Prostate Cancer
por: Fortis, Sotirios P., et al.
Publicado: (2022)

T-Cell Repertoire in Tumor Radiation: The Emerging Frontier as a Radiotherapy Biomarker
por: Baxevanis, Constantin N., et al.
Publicado: (2022)

DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival
por: Papalouka, Chara, et al.
Publicado: (2023)

Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head–Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay
por: Koukourakis, Michael I., et al.
Publicado: (2023)

Cancer Dormancy: A Regulatory Role for Endogenous Immunity in Establishing and Maintaining the Tumor Dormant State
por: Baxevanis, Constantin N., et al.
Publicado: (2015)

Endogenous immunity at the forefront of tumor dormancy
por: Baxevanis, Constantin N, et al.
Publicado: (2015)

Correction: Kogionou et al. Radiotherapy-Related Gene Signature in Prostate Cancer. Cancers 2022, 14, 5032
por: Kogionou, Paraskevi, et al.
Publicado: (2023)

Linking tumor with systemic environment in the search for novel biomarkers in breast cancer
por: Fortis, Sotirios P, et al.
Publicado: (2015)

Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits?
por: Baxevanis, Constantin N.
Publicado: (2023)

Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide
por: Voutsas, Ioannis F., et al.
Publicado: (2016)

Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence
por: Brown, Tommy A., et al.
Publicado: (2020)

New insights into the role of NK cells in cancer immunotherapy
por: Salagianni, Maria, et al.
Publicado: (2012)

The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias
por: Tzifi, Flora, et al.
Publicado: (2012)

The impact of radiation therapy on the TCR Vβ chain repertoire in patients with prostate cancer
por: Goulielmaki, Maria, et al.
Publicado: (2022)

Biomarkers in the Era of Precision Oncology
por: Baxevanis, Constantin N.
Publicado: (2023)

Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues
por: Russo, Ethan B.
Publicado: (2016)

Predictors for the development of cholangiocarcinoma and hepatocellular carcinoma: in search for the most accurate biomarker
por: Tzovaras, Alexandros A., et al.
Publicado: (2011)

Exploring the essential need for developing COVID-19 vaccines in the Philippines
por: Cordero, Dalmacito A.
Publicado: (2023)

The mannosylated extracellular domain of Her2/neu produced in P. pastoris induces protective antitumor immunity
por: Dimitriadis, Alexios, et al.
Publicado: (2009)

Special Issue on ‘Coronavirus: Vaccines and Other Therapeutics’ (2020–2021)
por: Basu, Sankar
Publicado: (2021)

Issues of therapeutic communication relevant for improving quality of care
por: Popa-Velea, O, et al.
Publicado: (2014)

Personal Health Record Design: Qualitative Exploration of Issues Inhibiting Optimal Use
por: Fuji, Kevin T., et al.
Publicado: (2014)

Exploring the heterogeneous morphometric data in essential tremor with probabilistic modelling
por: Bolton, Thomas A.W., et al.
Publicado: (2022)

A multicenter clinical trial to assess the efficacy of the digital therapeutics for essential hypertension: Rationale and design of the HERB‐DH1 trial
por: Kario, Kazuomi, et al.
Publicado: (2020)

The STEP-HI Trial: Pragmatic Challenges and Design Issues
por: Binder, Ellen
Publicado: (2021)

Bilateral De Quervain Syndrome after Aromatase Inhibitor Administration: A Case Report and Review of the Literature
por: Papadimitriou, Konstantinos, et al.
Publicado: (2012)

Epidemiological characteristics, clinical outcomes and management patterns of metastatic breast cancer patients in routine clinical care settings of Greece: Results from the EMERGE multicenter retrospective chart review study
por: Kotsakis, Athanasios, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2c8eecn1ee4ro96shbc3agoqm9